Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
Public ClinicalTrials.gov record NCT05172726. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects
Study identification
- NCT ID
- NCT05172726
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Organon and Co
- Industry
- Enrollment
- 58 participants
Conditions and interventions
Conditions
Interventions
- tapinarof cream, 1% Drug
Drug
Eligibility (public fields only)
- Age range
- 2 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 1, 2021
- Primary completion
- Sep 30, 2026
- Completion
- Sep 30, 2026
- Last update posted
- Apr 16, 2026
2021 – 2026
United States locations
- U.S. sites
- 12
- U.S. states
- 8
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Northwest Arkansas Clinical Trials Center, PLLC | Rogers | Arkansas | 72758 | — |
| First OC Dermatology | Fountain Valley | California | 92708 | — |
| Mission Dermatology Center | Rancho Santa Margarita | California | 92688 | — |
| RM Medical Research | Miami Lakes | Florida | 33014 | — |
| San Marcus Research Clinic, Inc. | Miami Lakes | Florida | 33014 | — |
| Olympian Clinical Research | Tampa | Florida | 33615 | — |
| Northwestern University Feinberg School of Medicine | Chicago | Illinois | 60611 | — |
| Dawes Fretzin Clinical Research Group | Indianapolis | Indiana | 46250 | — |
| Options Research Group | West Lafayette | Indiana | 47906 | — |
| Wright State Physicians Pharmacology Translational Unit | Fairborn | Ohio | 45324 | — |
| Oregon Dermatology & Research Center | Portland | Oregon | 97210 | — |
| Dermatology Specialists of Spokane | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05172726, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 16, 2026 · Synced May 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05172726 live on ClinicalTrials.gov.